PP
FLNA

Paloma Partners’s Filana Therapeutics FLNA Stock Holding History

Paloma Partners’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-8,379
Closed -$101K – 1880
2015
Q2 		$101K Buy
+8,379
New +$115K ﹤0.01% 1680
2013
Q3 		– Sell
-23,383
Closed -$362K – 1155
2013
Q2 		$362K Buy
+23,383
New +$494K 0.02% 592

Other funds holding FLNA

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Paloma Partners's FLNA Position: Q3 2015 in Review

Paloma Partners sold out of Filana Therapeutics (FLNA) in Q3 2015, closing a stake of 8,379 shares — an estimated $101K sold.

Paloma Partners first reported a position in FLNA in Q2 2013 and held it in 2 quarters. The position peaked at $362K in Q2 2013. 49 funds tracked by Wall St. Rank hold FLNA as of Q3 2015.

  • Paloma Partners reported no remaining Filana Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Paloma Partners sold 8,379 Filana Therapeutics shares in Q3 2015, an estimated $101K.
  • Paloma Partners first reported a position in Filana Therapeutics in Q2 2013 and held it in 2 quarters.
  • Paloma Partners's Filana Therapeutics position peaked at $362K in Q2 2013.
  • 49 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2015.

Based on Paloma Partners's 13F filing for Q3 2015, filed 16 Nov 2015.